clarithromycin has been researched along with Cancer of Stomach in 147 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (10.20) | 18.2507 |
2000's | 62 (42.18) | 29.6817 |
2010's | 57 (38.78) | 24.3611 |
2020's | 13 (8.84) | 2.80 |
Authors | Studies |
---|---|
Cheng, WC; Hsu, TL; Liou, JM; Tseng, YY; Wong, CH; Wu, MS | 1 |
He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X | 1 |
Hubscher, E; Jacob, R; Pelletier, C; Shah, S; Vinals, L; Yadlapati, R | 1 |
Chan, P; Cheung, K; Deng, Z; Han, S; Li, K; Li, Y; Luo, X; Lyu, T; Ni, L | 1 |
Desai, T; Edhi, AI; Hakim, S | 1 |
Bair, MJ; Chen, CL; Chen, HH; Chia, SL; Chiang, TH; Chu, CH; Chuang, SL; Chung Lo, YT; Jou, YY; Lee, YC; Lei, WY; Lin, CC; Su, WW; Tian, HW; Wang, YW; Wu, CY; Wu, MS | 1 |
Jeon, SW; Kwon, YH; Lee, HS; Lee, SW; Nam, SY | 1 |
Choi, IJ; Joo, J; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Park, B | 1 |
Beheshtirouy, S; Eyvazi, S; Tarhriz, V | 1 |
Cogdill, AG; Guevara, B | 1 |
Fujimura, S; Gold, BD; Ida, S; Ishige, T; Kamiya, S; Kato, S; Konno, M; Kuwabara, K; Nakayama, Y; Shimizu, T; Toyoda, S; Ushijima, K; Yoshimura, N | 1 |
Cho, SJ; Choi, J; Chung, H; Chung, SJ; Kim, JL; Kim, SG; Lee, A | 1 |
Graham, DY; Howden, CW | 1 |
Kizawa, K; Kosone, T; Marubashi, K; Takagi, H; Takakusagi, S; Tojima, H; Yokoyama, Y | 1 |
Chen, B; Jin, S; Jin, Y; Li, Y; Lin, R; Wu, X | 1 |
Barboza, KP; Castelar, BM; da Silva, FC; Lemos, LVB; Ribeiro, AEL; Souto Filho, JTD; Vieira Junior, MC | 1 |
Itoh, F; Kato, M; Mabe, K; Miyamoto, S; Oikawa, R; Ono, S; Sato, Y; Watanabe, Y; Yamamoto, H | 1 |
Chan, EW; Chen, L; Cheung, KS; Leung, WK; Wong, AYS; Wong, ICK | 1 |
Keller, PM; Redondo, JJ; Wagner, K; Zbinden, R | 1 |
Mori, H; Suzuki, H | 1 |
Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, AYS; Wong, ICK | 2 |
Chan, EW; Chen, L; Cheung, KS; Graham, DY; Leung, WK; Wong, AYS; Wong, ICK; Wong, IOL; Yeung, KF | 1 |
Cho, SJ; Choi, IJ; Kim, CG; Kim, YI; Kook, MC; Lee, JY; Nam, BH; Park, B | 1 |
Salar, A | 1 |
Choi, IJ | 1 |
Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, ICK | 1 |
Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Sexton, R; Torres, J; Valdivieso, M | 1 |
Malfertheiner, P | 1 |
Jang, JY; Jung, HK; Kim, CG; Kim, SG; Lee, H; Lee, HL; Lee, YC; Shin, ES; Shin, WG | 1 |
Labenz, J | 1 |
Bosques-Padilla, FJ; Garza-González, E; Maldonado-Garza, HJ; Perez-Perez, GI | 1 |
Cui, R; Ding, S; Guo, C; Huang, X; Jin, Z; Li, Y; Lin, S; Meng, L; Xue, Y; Yan, X; Zhang, J; Zhang, L; Zhou, L | 1 |
Kato, M | 1 |
Choi, SK; Joo, YE; Jun, CH; Kim, HS; Koh, HR; Lee, SM; Lee, WS; Park, CH; Park, CS; Park, SY; Rew, JS | 1 |
Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S | 1 |
Malfertheiner, P; Selgrad, M | 1 |
Tu, S; Yang, H | 1 |
Fischbach, W; Glocker, E; Malfertheiner, P; Scherübl, H | 1 |
Inoue, S; Itagaki, T; Kagemoto, K; Mitsui, Y; Muguruma, N; Naruse, K; Takayama, T | 1 |
Aponte-Pieras, JR; Lee, DS; Morrissey, R; Moss, SF; Rogers, AB; Zhang, S | 1 |
Donadoni, G; Ferreri, AJ; Govi, S; Kiesewetter, B; Raderer, M; Sassone, M; Scarfò, L | 1 |
Hashimoto, Y; Hiki, N; Honda, M; Kamiya, S; Kumagai, K; Mine, S; Nunobe, S; Ohashi, M; Sano, T; Yamaguchi, T | 1 |
Grgov, S; Katić, V; Krstić, M; Nagorni, A; Radovanović-Dinić, B; Tasić, T | 1 |
Annibale, B; Calabrese, C; Caselli, M; Di Mario, F; Farinati, F; Gasbarrini, G; Gullini, S; Ierardi, E; Luzza, F; Maconi, G; Ojetti, V; Pretolani, S; Romano, M; Rugge, M; Savio, A; Stockbrugger, R; Zagari, RM | 1 |
Georgopoulos, SD; Karatapanis, S; Papastergiou, V | 1 |
Chun, J; Kim, BG; Kim, BS; Kim, JS; Kim, JW; Koh, SJ; Lee, KL; Oh, B | 1 |
Li, JY; Ma, JL; Pan, KF; Shen, L; You, WC; Zhang, L; Zhang, Y; Zhou, T | 1 |
Chung, HS; Jung, DH; Kim, JH; Lee, SK; Lee, YC; Park, JC; Shin, SH; Shin, SK | 1 |
Fukayama, M; Hayakawa, Y; Hirata, Y; Koike, K; Niikura, R; Shichijo, S; Ushiku, T; Yamada, A | 1 |
Bilgilier, C; Dolak, W; Kiesewetter, B; Makristathis, A; Raderer, M; Simonitsch-Klupp, I; Steininger, C | 1 |
Hillard, JR; Laird-Fick, HS; Saini, S | 1 |
Katelaris, P; Mitchell, H | 1 |
Becquart, JP; Camuset, G; Gérardin, P; Guillemot, G; Jaubert, J; Kwiatek, S; Michault, A; Picot, S; Thomas, E; Zemali, N | 1 |
Huh, CW; Jung, da H; Kim, JH; Park, H; Park, JJ; Youn, YH | 1 |
Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gasbarrini, A; Gisbert, JP; Graham, DY; Hunt, R; Kuipers, EJ; Malfertheiner, P; Megraud, F; Moayyedi, P; O'Morain, CA; Rokkas, T; Rugge, M; Selgrad, M; Suerbaum, S; Sugano, K | 1 |
Asaka, M; Itoh, T; Kato, M; Kubota, K; Nakagawa, M; Ono, S; Ono, Y; Shimizu, Y | 1 |
Amagai, K; Asaka, M; Fukase, K; Hayashi, S; Inoue, K; Kato, M; Kikuchi, S; Okamoto, S; Terao, S; Uemura, N | 1 |
Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, SK; Lee, YC | 1 |
Fukase, K; Kawata, S; Mabe, K; Matsuda, T; Oizumi, H; Shibata, A; Takahashi, M; Takeda, H; Tsukuma, H | 1 |
Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N | 1 |
Cabras, A; Carbone, A; Devizzi, L; Gianni, AM; Mirabile, A | 1 |
Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
Francesconi, CF; Mazzoleni, LE; Sander, GB | 1 |
Jung, SW; Kim, SY | 1 |
Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS | 1 |
Bornschein, J; Malfertheiner, P; Selgrad, M | 1 |
Feng, GS; Lam, S; Li, J; Li, JY; Liu, WD; Lu, AP; Ma, JL; Pan, KF; Shen, L; Wong, BC; Xia, HH; You, WC; Zhang, L; Zhang, XD | 1 |
Haruma, K; Iishi, H; Inoue, K; Kamada, T; Kanzaki, T; Kimura, Y; Kusunoki, H; Murao, T; Shiotani, A; Uedo, N | 1 |
Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gensini, GF; Gisbert, JP; Graham, DY; Kuipers, EJ; Malfertheiner, P; Megraud, F; O'Morain, CA; Rokkas, T | 1 |
Chen, TH; Chiang, H; Chiu, HM; Lee, YC; Lin, JT; Liu, TY; Shun, CT; Wu, MS | 1 |
Buzás, GM | 1 |
Cerqueira, RM; Correia, MR; Fernandes, CD; Manso, MC; Vilar, H | 1 |
Hibi, T; Nishizawa, T; Suzuki, H; Tsugawa, H | 1 |
Cho, WY; Choi, IJ; Jung, HC; Keum, B; Kim, JG; Kim, SG; Lee, JH; Lee, YC; Park, BJ; Park, SK; Song, HJ | 1 |
Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J | 1 |
Go, MF | 1 |
Bueno, ML; Castro, LP; Coelho, LG; Lopes, LG; Martins, GM; Miranda, CH; Passos, MC; Sanches, BS | 1 |
Schuster, MJ | 1 |
Arima, N; Tsudo, M | 1 |
Asaka, M | 1 |
Cruz Vicente, JM; Fernández Fernández, F; González Macías, J; Olmos Martínez, JM | 1 |
Dragosics, B; Fischbach, W; Goebeler-Kolve, ME; Greiner, A; Stolte, M | 1 |
Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Ogawa, K | 1 |
Furuta, Y; Miyasaka, K; Sugiyama, T; Yoshioka, M | 1 |
Chan, FK; Ching, JY; Lau, JY; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF | 1 |
Fukuda, Y; Sakagami, T | 1 |
Schuster, M | 1 |
de Mascarel, A; Dubus, P; Lavergne-Slove, A; Megraud, F; Merlio, JP; Ruskone-Fourmestraux, A | 1 |
Hara, H; Miyokawa, N; Ohtubo, C; Sano, H; Tanabe, H | 1 |
Alfaresi, MS; Aljenaibi, MM; Alshaikh, SS; Buchel, EH; Eltom, AA; Saeed, LS | 1 |
Demiray, E; Yilmaz, O | 1 |
Kaminishi, M; Kubota, K; Shimizu, N | 1 |
Chen, JY; Ji, F; Li, YM; Ning, JW; Wang, QY; Wang, ZW | 1 |
Asaka, M; Kato, M; Katsuyama, T; Kikuchi, S; Tominaga, S | 1 |
Desar, IM; Jansen, JB; Keuter, M; Raemaekers, JM; van der Meer, JW; van Krieken, JH | 1 |
Hirakawa, K; Inoue, T; Komoto, M; Nakata, B; Takashima, T; Tominaga, K | 1 |
Stege, PW; Vega, AE | 1 |
Byeon, JS; Choi, KD; Hong, SS; Hong, WS; Jo, JY; Jung, HY; Kim, JH; Kim, KJ; Lee, GH; Min, YI; Myung, SJ; Oh, TH; Song, HJ; Yang, SK | 1 |
Bertoli Neto, JL; Bertoli, CF; Bueno, AG; Lourenço, LG; Sabbi, AR; Ulbrich, FS | 1 |
Haruma, K; Iishi, H; Ishiguro, S; Kamada, T; Merchant, JL; Nakae, Y; Shiotani, A; Tatsuta, M; Uedo, N | 1 |
Hirasaki, S; Ikeda, F; Matsubara, M; Suzuki, S; Taniguchi, H | 1 |
Bae, JM; Choi, IJ; Hong, EK; Kim, CG; Kim, YW; Kook, MC; Lee, JH; Lee, JY; Park, S; Ryu, KW; Song, HJ | 1 |
Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK | 1 |
Amenta, PS; Das, KK; Das, KM; Geng, X; Kohgo, Y; Lin, JJ; Tanabe, H; Tanaka, A; Watari, J | 1 |
Cavanna, L; Pagani, R; Paties, C; Seghini, P; Zangrandi, A | 1 |
Fujioka, T; Kodama, M; Murakami, K; Okimoto, T | 1 |
Fox, JG; Ge, Z; Lee, CW; Rickman, B; Rogers, AB; Wang, TC | 1 |
Reed, PI | 1 |
Roesch, W | 1 |
Buiatti, E; Kato, I; Muñoz, N; Oliver, W; Vivas, J | 1 |
Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S | 1 |
Isomoto, H; Kohno, S; Matsunaga, K; Mizuta, Y; Oofukuji, M; Osabe, M; Syukuwa, S; Takeno, Y | 1 |
Cammarota, G; Cannizzaro, O; Cianci, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, G; Papa, A; Tursi, A | 1 |
Aoyama, N | 1 |
Asaka, M; Hirayama, Y; Nakamura, T; Takahashi, S; Uemura, N | 1 |
Ariake, K; Fujiki, K; Horiuchi, T; Ishii, K; Kumagai, J; Ohkusa, T; Sakurazawa, T; Shimoi, K; Suzuki, S; Takashimizu, I; Tanizawa, T | 1 |
Tytgat, GN; van 't Hoff, BW; van der Ende, A; van der Hulst, RW | 1 |
Labenz, J; Stolte, M | 1 |
Bruno, S; Bustos Fernandez, LM; Gonzalez Cueto, D; Narbaitz, M | 1 |
Borda, F; Domínguez, E; Gisbert, JP; Sainz, R | 1 |
Fujishiro, M; Gotoda, T; Kondo, H; Oda, I; Ono, H; Saito, D; Yamaguchi, H | 1 |
Bueno, ML; Castro, LP; Coelho, LG; Gomes, BS; Lopes, LG; Martins, GM; Passos, MC | 1 |
Blackington, E | 1 |
Adamsson, I; Edlund, C; Nord, CE | 1 |
Atha, P; Axon, AT; Brown, J; Crocombe, W; Dowell, AC; Feltbower, R; Mason, S; Moayyedi, P; Richards, ID | 1 |
Arai, K; Kobayashi, R; Mori, M; Ohki, I; Saito, K | 1 |
Ajioka, Y; Fujino, MA; Maruta, K; Nishikura, K; Watanabe, H; Yamashita, H | 1 |
Hentschel, E | 1 |
Fukuda, S; Munakata, A; Nishiya, D; Shimoyama, T; Suto, T; Umegaki, N | 1 |
Aegerter, PH; de Mascarel, A; Lavergne, A; Megraud, F; Molina, T; Palazzo, L; Rambaud, JL; Ruskoné-Fourmestraux, A | 1 |
Harada, H; Kobayashi, S; Miki, H; Ohmori, M; Sotozono, M; Uraoka, T; Yamanoi, Y | 1 |
Arakawa, Y; Ishii, Y; Kato, K; Kawamura, F; Kawamura, Y; Komuro, S; Nagata, T; Nemoto, N; Nishinarita, S; Sugitani, M; Takahashi, Y; Yanai, M | 1 |
Chayama, K; Haruma, K; Hiyama, T; Ito, M; Kitadai, Y; Masuda, H; Miyamoto, M; Shimamoto, F; Sumii, K; Tanaka, S; Yoshihara, M | 1 |
Azuma, T; Dojo, M; Ito, Y; Kato, T; Kuriyama, M; Ohtani, M; Suto, H | 1 |
Hirakoba, M; Kume, K; Murata, I; Otsuki, M; Yoshikawa, I | 1 |
Bigard, MA | 1 |
Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 1 |
Ebata, M; Keto, Y; Okabe, S | 1 |
Alpen, B; Neubauer, A; Röbbecke, J; Stolte, M; Wündisch, T | 1 |
Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M | 1 |
Sung, JJ; Wu, JC | 1 |
Jung, HC; Kim, CW; Kim, CY; Kim, JS; Kim, YS; Lee, CH; Song, IS | 1 |
Brousse, N; Copie-Bergman, C; de Mascarel, A; Delchier, JC; Flejou, JF; Gaulard, P; Hemery, F; Lavergne-Slove, A; Levy, M; Traulle, C | 1 |
Dolan, PM; Fahey, JW; Haristoy, X; Kensler, TW; Lozniewski, A; Scholtus, I; Stephenson, KK; Talalay, P | 1 |
41 review(s) available for clarithromycin and Cancer of Stomach
Article | Year |
---|---|
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Delphi Technique; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Japan; Microbial Sensitivity Tests; Proton Pump Inhibitors; Stomach Neoplasms | 2020 |
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Plasmacytoma; Remission Induction; Stomach Neoplasms | 2017 |
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; Gastritis; Health Planning Guidelines; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Japan; Metronidazole; National Health Programs; Quinolones; Rifabutin; Stomach Neoplasms | 2018 |
Gastric MALT lymphoma and Helicobacter pylori.
Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Organometallic Compounds; Practice Guidelines as Topic; Proton Pump Inhibitors; Salvage Therapy; Stomach Neoplasms | 2019 |
[
Topics: Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Guidelines as Topic; Helicobacter Infections; Meta-Analysis as Topic; Proportional Hazards Models; Stomach Neoplasms | 2018 |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
Topics: Anti-Bacterial Agents; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Probiotics; Reproducibility of Results; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome; Urea; Urease | 2014 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; National Health Programs; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2014 |
Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms | 2014 |
[What is new in treating Helicobacter pylori infection?].
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Quinolones; Stomach Neoplasms | 2015 |
Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.
Topics: Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Stomach Neoplasms | 2015 |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Early Detection of Cancer; Helicobacter Infections; Helicobacter pylori; Humans; Mass Screening; Prevalence; Primary Prevention; Proton Pump Inhibitors; Risk Assessment; Socioeconomic Factors; Stomach Neoplasms | 2016 |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; New Zealand; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Treatment Outcome | 2016 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
[Helicobacter pylori eradication therapy in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
[Helicobacter pylori: an infection with local complications and systemic effects].
Topics: Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Asthma; Clarithromycin; Cross-Sectional Studies; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Metronidazole; Obesity; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Risk Factors; Stomach Neoplasms; Virulence | 2011 |
[Helicobacter pylori - 2012].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Emigrants and Immigrants; Endoscopy, Gastrointestinal; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; In Situ Hybridization, Fluorescence; Levofloxacin; Ofloxacin; Peptic Ulcer; Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Gene Expression Regulation, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Virulence | 2012 |
Treatment and management of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Cardiovascular Diseases; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2002 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Follow-Up Studies; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Risk; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Time Factors | 2002 |
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Stomach Neoplasms; Thyroid Neoplasms; Thyroiditis, Autoimmune | 2003 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Microbiology; Omeprazole; Peptic Ulcer; Polyps; Practice Guidelines as Topic; Proton Pump Inhibitors; Societies, Medical; Stomach Neoplasms | 2003 |
[What is Helicobacter pylori?: associated diseases in human].
Topics: Amoxicillin; Animals; Clarithromycin; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 2004 |
[The several problems and cautions in treatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention; Stomach Neoplasms | 2004 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
[Eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Stomach Neoplasms; Sulfoxides | 2005 |
[Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Stomach Neoplasms; Stomach Ulcer | 2005 |
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Stump; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Stomach Neoplasms; Tranexamic Acid | 2005 |
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms | 2008 |
[Guidelines for the management of Helicobacter pylori--Maastricht III-2005 and Japanese guidelines].
Topics: Amoxicillin; Clarithromycin; Consensus Development Conferences as Topic; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Practice Guidelines as Topic; Proton Pump Inhibitors; Stomach Neoplasms | 2008 |
Cost-effectiveness of H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Markov Chains; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms; Treatment Outcome | 1996 |
[Efficacy of antibiotic therapy in eradicating Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms | 1998 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Stomach Ulcer | 1999 |
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection].
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Plasmacytoma; Stomach Neoplasms | 1999 |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Duodenitis; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lymphoma, B-Cell, Marginal Zone; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Ranitidine; Stomach Neoplasms; Stomach Ulcer | 1999 |
The gastric demon. An update on Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nurse Practitioners; Peptic Ulcer; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine; Stomach Neoplasms | 2000 |
[Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Peptic Ulcer; Stomach Neoplasms | 2001 |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indomethacin; Omeprazole; Recurrence; Stomach Neoplasms; Stomach Ulcer | 2001 |
Ulcer and gastritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Precancerous Conditions; Proton Pump Inhibitors; Rifabutin; Stomach Neoplasms | 2002 |
37 trial(s) available for clarithromycin and Cancer of Stomach
Article | Year |
---|---|
Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms; Treatment Outcome | 2023 |
Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.
Topics: Adenomatous Polyps; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Monitoring; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Outcome Assessment, Health Care; Proton Pump Inhibitors; Stomach Neoplasms | 2020 |
Family History of Gastric Cancer and
Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Kaplan-Meier Estimate; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2020 |
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Republic of Korea; RNA, Ribosomal, 23S; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2020 |
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.
Topics: Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Stomach; Stomach Neoplasms | 2018 |
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Latin America; Male; Medication Adherence; Metronidazole; Middle Aged; Primary Prevention; Recurrence; Risk; Stomach Neoplasms; Young Adult | 2013 |
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Peptic Ulcer; Stomach Neoplasms; Taiwan | 2013 |
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Neoplasms | 2014 |
Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms, Glandular and Epithelial; Proton Pump Inhibitors; Stomach Neoplasms | 2014 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinolones; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2015 |
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breast Neoplasms; Clarithromycin; Colorectal Neoplasms; Disease-Free Survival; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Salvage Therapy; Skin Neoplasms; Stomach Neoplasms | 2015 |
Preoperative vs Postoperative Eradication of Helicobacter pylori in 150 Patients with Gastric Cancer: A Randomized Controlled Trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Postoperative Care; Preoperative Care; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2015 |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Ribosomal; Drug Therapy, Combination; Female; Gastritis; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Lansoprazole; Male; Middle Aged; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Sequence Analysis, DNA; Stomach Neoplasms | 2016 |
Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; China; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach; Stomach Neoplasms | 2015 |
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Endpoint Determination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms | 2008 |
Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2008 |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Stomach Neoplasms; Young Adult | 2009 |
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; Clarithromycin; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Pyrazoles; Stomach; Stomach Neoplasms; Sulfonamides | 2012 |
Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2013 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastrins; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Precancerous Conditions; Recurrence; Risk Factors; ROC Curve; Stomach Neoplasms | 2002 |
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Family Health; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Neoplasms; Tablets; Treatment Outcome | 2003 |
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2004 |
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metaplasia; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Risk Factors; Stomach Neoplasms | 2004 |
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Polyps; Proton Pump Inhibitors; Stomach Neoplasms; Tinidazole | 2006 |
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Protocols; Combined Modality Therapy; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Middle Aged; Omeprazole; Proportional Hazards Models; Research Design; Sample Size; Stomach Neoplasms | 2006 |
A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Proton Pumps; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2006 |
Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Follow-Up Studies; Gastrectomy; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Postoperative Care; Preoperative Care; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2008 |
The ECP-IM intervention study.
Topics: Ascorbic Acid; Clarithromycin; Double-Blind Method; Drug Combinations; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Placebos; Stomach Neoplasms | 1994 |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Placebos; Precancerous Conditions; Stomach Neoplasms; Vitamins | 1996 |
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polyps; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms | 1998 |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Ethics, Medical; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Risk Factors; Stomach Neoplasms | 1999 |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Family; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Stomach Neoplasms | 2000 |
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Omeprazole; Patient Compliance; Sex Factors; Stomach Neoplasms; Tinidazole; Treatment Outcome | 2000 |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma.
Topics: Adenoma; Aged; Aged, 80 and over; Amoxicillin; Carcinoma; Cell Transformation, Neoplastic; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Omeprazole; Probability; Reference Values; Statistics, Nonparametric; Stomach Neoplasms; Treatment Outcome | 2000 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Metronidazole; Omeprazole; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2001 |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms | 2001 |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2002 |
69 other study(ies) available for clarithromycin and Cancer of Stomach
Article | Year |
---|---|
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Conformation; Stomach Neoplasms; Stomach Ulcer | 2014 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Stomach; Stomach Neoplasms; Tinidazole | 2021 |
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Stomach Neoplasms; Systematic Reviews as Topic; Treatment Failure | 2022 |
Eradicating H. pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States | 2019 |
Planning mass eradication of Helicobacter pylori infection for indigenous Taiwanese peoples to reduce gastric cancer.
Topics: Areca; Clarithromycin; Cost of Illness; Drug Therapy, Combination; Gastritis; Healthcare Disparities; Helicobacter Infections; Helicobacter pylori; Incidence; Indigenous Peoples; Prevalence; Risk Factors; Smoking; Stomach Neoplasms; Taiwan | 2020 |
Evaluation of Mutations in 23S rRNA, rdxA and frxA Genes of Helicobacter pylori in Paraffin-Embedded Gastric Biopsy Specimens from Iranian Gastric Cancer and Gastritis Patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Molecular Epidemiology; Mutation; Nitroreductases; Retrospective Studies; RNA, Ribosomal, 23S; Stomach Neoplasms | 2021 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
Changes of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Positron-Emission Tomography; Stomach; Stomach Neoplasms; Tomography | 2021 |
Genotyping Helicobacter pylori antibiotic resistance and virulence-associated genes in patients with gastric cancer in Wenzhou, China.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Stomach Neoplasms; Virulence | 2021 |
Enrichment of Helicobacter pylori mutant strains after eradication therapy analyzed by gastric wash-based quantitative pyrosequencing.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Fluids; Clarithromycin; DNA, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Neoplasms; Therapeutic Irrigation | 2017 |
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Databases, Factual; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Incidence; Male; Middle Aged; Proton Pump Inhibitors; Risk Assessment; Stomach Neoplasms | 2018 |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 23S; Stomach Neoplasms | 2018 |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study.
Topics: Adult; Aged; Aspirin; Chemoprevention; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Remission Induction; Risk Factors; Stomach Neoplasms | 2018 |
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Incidence; Levofloxacin; Male; Middle Aged; Protective Factors; Proton Pump Inhibitors; Registries; Retrospective Studies; Risk Factors; Stomach Neoplasms | 2018 |
Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.
Topics: Aged; Anti-Bacterial Agents; Blood Glucose; Clarithromycin; Cohort Studies; Diabetes Mellitus; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Propensity Score; Proportional Hazards Models; Risk Factors; Stomach Neoplasms; Time Factors | 2019 |
Diabetes Increases Risk of Gastric Cancer After
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Diabetes Mellitus, Type 2; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Risk Factors; Stomach Neoplasms | 2019 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metaplasia; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms; Tetracycline | 2013 |
[Fewer stomach cancers after Helicobacter pylori eradication].
Topics: Clarithromycin; Cross-Sectional Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Mass Screening; Precancerous Conditions; Stomach Neoplasms; Stomach Ulcer | 2013 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Metronidazole; Peptic Ulcer; Probiotics; Stomach Neoplasms | 2014 |
Gastric inflammatory fibroid polyp morphologically changed by Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy, Digestive System; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polyps; Proton Pump Inhibitors; Rabeprazole; Stomach Neoplasms | 2015 |
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Chemokine CXCL10; Chemokine CXCL9; Clarithromycin; Gastric Mucosa; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice, Inbred C57BL; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 2015 |
Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Disease-Free Survival; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Grading; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2015 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Barrett Esophagus; Bismuth; Breath Tests; Clarithromycin; Disease Management; Drug Therapy, Combination; Dyspepsia; Feces; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Italy; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Urea | 2015 |
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Carcinoma in Situ; Clarithromycin; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proton Pump Inhibitors; Retrospective Studies; Stomach; Stomach Neoplasms | 2015 |
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Breath Tests; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Proportional Hazards Models; Proton Pump Inhibitors; Pyloric Antrum; Retrospective Studies; Risk Factors; Stomach; Stomach Neoplasms | 2016 |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Retrospective Studies; Stomach Neoplasms | 2016 |
Helicobacter pylori resistance to clarithromycin in Reunion Island.
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Gastric Fundus; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Mutation; Proton Pump Inhibitors; Pyloric Antrum; Reunion; Stomach Neoplasms | 2016 |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Proton Pump Inhibitors; Stomach Neoplasms; Time-to-Treatment; Treatment Outcome | 2016 |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Early Detection of Cancer; Evidence-Based Medicine; Fluoroquinolones; Gastritis; Gastrointestinal Microbiome; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach; Stomach Neoplasms | 2017 |
Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Pilot Projects; Retrospective Studies; Stomach Neoplasms | 2008 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Tetracycline | 2009 |
MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clarithromycin; Cyclophosphamide; Gastritis; Helicobacter Infections; Helicobacter pylori; Herpesvirus 8, Human; HIV Seronegativity; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Prednisone; Proton Pump Inhibitors; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms; Stomach Ulcer; Vinblastine; Vincristine | 2010 |
Mass eradication of Helicobacter pylori: feasible and advisable?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Drugs, Generic; Feasibility Studies; Female; Health Policy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2011 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metaplasia; MicroRNAs; Middle Aged; Proto-Oncogene Proteins; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms | 2012 |
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Prebiotics; Probiotics; Proton Pump Inhibitors; Stomach Neoplasms | 2012 |
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.
Topics: Adult; Algorithms; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metaplasia; Middle Aged; Multiphasic Screening; Odds Ratio; Peptic Ulcer; Precancerous Conditions; Prevalence; Recurrence; Risk Factors; Stomach Neoplasms; Taiwan; Treatment Outcome | 2013 |
Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Obesity, Morbid; Ofloxacin; Portugal; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Surgical Wound Infection; Treatment Failure; Young Adult | 2013 |
[Patient with increased stomach cancer risk. Helicobacter can cause damage here].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Precancerous Conditions; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sulfoxides | 2002 |
[Definitive treatment of Helicobacter pylori infection in MALT low degree gastric lymphoma].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Remission Induction; Stomach Neoplasms | 2003 |
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Clarithromycin; Female; Gastrectomy; Gastric Mucosa; Gastroenterostomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Stomach Neoplasms; Treatment Outcome | 2004 |
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gene Rearrangement; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin Heavy Chains; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prognosis; Remission Induction; Stomach Neoplasms | 2005 |
[Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Polyps; Stomach Neoplasms | 2005 |
Molecular prevalence of point mutations conferring resistance to clarithromycin in Helicobacter pylori in the United Arab Emirates.
Topics: Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter pylori; Humans; Male; Point Mutation; Polymerase Chain Reaction; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Saudi Arabia; Stomach Neoplasms | 2005 |
Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Common Variable Immunodeficiency; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Stomach Neoplasms | 2006 |
Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Remission Induction; Stomach Neoplasms | 2006 |
Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina.
Topics: Argentina; Bacterial Outer Membrane Proteins; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Peptic Ulcer; Point Mutation; RNA, Ribosomal, 23S; Stomach Neoplasms | 2006 |
Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Stomach Neoplasms | 2006 |
Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers, Tumor; Case-Control Studies; CDX2 Transcription Factor; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Hedgehog Proteins; Helicobacter Infections; Helicobacter pylori; Homeodomain Proteins; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Metaplasia; Middle Aged; Pepsinogen A; Precancerous Conditions; Stomach Neoplasms | 2007 |
Gastric inflammatory fibroid polyp treated with Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Polyps; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2007 |
Effect of Helicobacter pylori eradication on gastric carcinogenesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors | 2008 |
Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Antibodies; Biopsy; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Middle Aged; Phenotype; Prospective Studies; Stomach; Stomach Neoplasms; Tropomyosin; Tumor Suppressor Protein p53 | 2008 |
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithromycin; Disease Progression; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lithostathine; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Omeprazole; Precancerous Conditions; Stomach Neoplasms; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2008 |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1997 |
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Diterpenes; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Polymerase Chain Reaction; Pyloric Antrum; Stomach Neoplasms; Stomach Ulcer | 1997 |
[Topics on Helicobacter pylori (discussion)].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Stomach Neoplasms | 1998 |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1999 |
When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proton Pump Inhibitors; Remission Induction; Stomach; Stomach Neoplasms; Time Factors | 2000 |
Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan.
Topics: Anti-Bacterial Agents; Biopsy; Case-Control Studies; Clarithromycin; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Gastritis; Helicobacter pylori; Humans; Japan; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; RNA, Bacterial; RNA, Ribosomal, 23S; Stomach Neoplasms | 2000 |
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Omeprazole; Penicillins; Prospective Studies; Remission Induction; Stomach Neoplasms | 2001 |
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms | 2001 |
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Plasmacytoma; Stomach Neoplasms; Treatment Outcome | 2001 |
Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Female; Follow-Up Studies; Genetic Markers; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Microsatellite Repeats; Middle Aged; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins p21(ras); Stomach Neoplasms; Time Factors; Tumor Suppressor Protein p53 | 2001 |
Gastric leptin and Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biomarkers; Biopsy; Body Mass Index; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leptin; Male; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Stomach Neoplasms | 2001 |
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Omeprazole; Penicillins; Polyps; Remission Induction; Stomach; Stomach Neoplasms | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gene Expression; Genes, p16; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2002 |
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.
Topics: Agaricales; Amoxicillin; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Brassica; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter pylori; Humans; Isothiocyanates; Metronidazole; Mice; Mice, Inbred ICR; Phytotherapy; Stomach Neoplasms; Sulfoxides; Thiocyanates | 2002 |